These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33600889)

  • 1. Brain-Specific Relative Biological Effectiveness of Protons Based on Long-term Outcome of Patients With Nasopharyngeal Carcinoma.
    Zhang YY; Huo WL; Goldberg SI; Slater JM; Adams JA; Deng XW; Sun Y; Ma J; Fullerton BC; Paganetti H; Loeffler JS; Lu HM; Chan AW
    Int J Radiat Oncol Biol Phys; 2021 Jul; 110(4):984-992. PubMed ID: 33600889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response curves for MRI-detected radiation-induced temporal lobe reactions in patients after proton and carbon ion therapy: Does the same RBE-weighted dose lead to the same biological effect?
    Gillmann C; Lomax AJ; Weber DC; Jäkel O; Karger CP
    Radiother Oncol; 2018 Jul; 128(1):109-114. PubMed ID: 29459152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal lobe reactions after carbon ion radiation therapy: comparison of relative biological effectiveness-weighted tolerance doses predicted by local effect models I and IV.
    Gillmann C; Jäkel O; Schlampp I; Karger CP
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1136-41. PubMed ID: 24661667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating Intensity Modulated Proton Therapy Relative to Passive Scattering Proton Therapy for Increased Vertebral Column Sparing in Craniospinal Irradiation in Growing Pediatric Patients.
    Giantsoudi D; Seco J; Eaton BR; Simeone FJ; Kooy H; Yock TI; Tarbell NJ; DeLaney TF; Adams J; Paganetti H; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):37-46. PubMed ID: 28587051
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
    Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can We Advance Proton Therapy for Prostate? Considering Alternative Beam Angles and Relative Biological Effectiveness Variations When Comparing Against Intensity Modulated Radiation Therapy.
    Underwood T; Giantsoudi D; Moteabbed M; Zietman A; Efstathiou J; Paganetti H; Lu HM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):454-464. PubMed ID: 27084660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parotid gland radiation dose-xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma.
    Lou J; Huang P; Ma C; Zheng Y; Chen J; Liang Y; Li H; Yin Y; Liu D; Yu G; Li D
    J Appl Clin Med Phys; 2018 May; 19(3):251-260. PubMed ID: 29664218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
    Traneus E; Ödén J
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
    Seco J; Gu G; Marcelos T; Kooy H; Willers H
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal lobe toxicity analysis after proton radiation therapy for skull base tumors.
    Pehlivan B; Ares C; Lomax AJ; Stadelmann O; Goitein G; Timmermann B; Schneider RA; Hug EB
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1432-40. PubMed ID: 22349042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes.
    Grosshans DR; Zhu XR; Melancon A; Allen PK; Poenisch F; Palmer M; McAleer MF; McGovern SL; Gillin M; DeMonte F; Chang EL; Brown PD; Mahajan A
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):540-6. PubMed ID: 25304948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
    Rana S; Zheng Y
    J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in LET-based biological doses between IMPT optimization techniques: Robust and PTV-based optimizations.
    Hirayama S; Matsuura T; Yasuda K; Takao S; Fujii T; Miyamoto N; Umegaki K; Shimizu S
    J Appl Clin Med Phys; 2020 Apr; 21(4):42-50. PubMed ID: 32150329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation-induced temporal lobe injury after intensity modulated radiotherapy in nasopharyngeal carcinoma patients: a dose-volume-outcome analysis.
    Sun Y; Zhou GQ; Qi ZY; Zhang L; Huang SM; Liu LZ; Li L; Lin AH; Ma J
    BMC Cancer; 2013 Aug; 13():397. PubMed ID: 23978128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperfractionated intensity-modulated proton therapy for pharyngeal cancer with variable relative biological effectiveness: A simulation study.
    Kasamatsu K; Matsuura T; Yasuda K; Miyazaki K; Takao S; Tamura M; Otsuka M; Uchinami Y; Aoyama H
    Med Phys; 2022 Dec; 49(12):7815-7825. PubMed ID: 36300598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
    Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of hippocampus dose for patients undergoing intensity-modulated radiotherapy for nasopharyngeal carcinoma.
    Khodayari B; Michaud AL; Stanic S; Wooten OH; Dublin A; Purdy JA; Chen AM
    Br J Radiol; 2014 May; 87(1037):20130474. PubMed ID: 24620838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-volume histogram prediction in volumetric modulated arc therapy for nasopharyngeal carcinomas based on uniform-intensity radiation with equal angle intervals.
    Zhuang Y; Han J; Chen L; Liu X
    Phys Med Biol; 2019 Dec; 64(23):23NT03. PubMed ID: 31683261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
    Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
    Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.